glp 1 pharma companies A $60 billion industry just found its next growth lever. 💊 With the expiry of a key patent on March 20, 2026, Indian majors are launching generic weight-loss and diabetes drugs GLP-1 Market Trends and Global

Inflammation reduction: Inflammation in the brain can also lead to OCD

More and more Americans are turning to GLP-1 medications for weight loss

Fasting state and circadian timing significantly modulate GH response to secretagogue administration. Ho , Journal of Clinical Endocrinology & Metabolism Individual Adjustments Beginners should start at the low end of the dosing range (100 mcg 2x/day) to assess tolerance and response

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy

Rajat Goel are helping people lose weight without going under the knife